Home » Topics » BioWorld Science

BioWorld Science
RSS

Kyowa Hakko's UCT-1072M1, a new antitumor antibiotic

Nov. 19, 1997

rhIGF-I + insulin combination tested in adolescents with IDDM

Nov. 19, 1997

Sch-207278: new protein farnesyltransferase inhibitor of microbial origin

Nov. 19, 1997

Potential new antiatherosclerotic agent discovered at Tanabe Seiyaku

Nov. 19, 1997

Sankyo and ArQule enter drug discovery collaboration

Nov. 19, 1997

Ibex issued U.S. patent for recombinant heparinase

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Scripps prepares MCBI analogues of antitumor antibiotics

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...